These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35527405)

  • 1. [Strengthening the prevention and treatment of Omicron infection in children].
    Jiao FY; Ma L
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Apr; 24(4):345-349. PubMed ID: 35527405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines.
    Araf Y; Akter F; Tang YD; Fatemi R; Parvez MSA; Zheng C; Hossain MG
    J Med Virol; 2022 May; 94(5):1825-1832. PubMed ID: 35023191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
    Ren B; Liao BY; Wang JN; Peng X; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological features of convalescent pediatric patients infected with the SARS-CoV-2 Omicron variant in Tianjin, China.
    Wang JY; Li TN; Zhou CL; Zhao J; Wang M; Wang Y; Jiang Y; Dong HN; Qi QR; Mu H
    Virol Sin; 2022 Dec; 37(6):850-859. PubMed ID: 36328182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis.
    Meo SA; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9470-9476. PubMed ID: 37843359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing.
    Fidan O; Mujwar S; Kciuk M
    Mol Divers; 2023 Feb; 27(1):463-475. PubMed ID: 35507211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
    Parums DV
    Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert.
    Temsah MH; Aljamaan F; Alenezi S; Alhasan K; Alrabiaah A; Assiri R; Bassrawi R; Alhaboob A; Alshahrani F; Alarabi M; Alaraj A; Alharbi NS; Halwani R; Jamal A; Al-Eyadhy A; AbdulMajeed N; Alfarra L; Almashdali W; Fayed A; Alzamil F; Barry M; Memish ZA; Al-Tawfiq JA; Alsubaie S
    Front Public Health; 2022; 10():878159. PubMed ID: 35400032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insights into SARS-CoV-2 omicron variant.
    Silva SJRD; Kohl A; Pena L; Pardee K
    Rev Med Virol; 2023 Jan; 33(1):e2373. PubMed ID: 35662313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence.
    SeyedAlinaghi S; Afsahi AM; Mirzapour P; Afzalian A; Shahidi R; Dashti M; Ghasemzadeh A; Paranjkhoo P; Parsaei Z; Pashaei A; Mohammadi P; Najafi MS; Mahrokhi S; Matini P; Moradi A; Karimi A; Afroughi S; Mehraeen E; Dadras O
    Infect Disord Drug Targets; 2024; 24(7):e050324227686. PubMed ID: 38445691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.
    Tan SHX; Cook AR; Heng D; Ong B; Lye DC; Tan KB
    N Engl J Med; 2022 Aug; 387(6):525-532. PubMed ID: 35857701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change in serum IgG antibody during the recovery stage of Omicron variant infection in children: an analysis of 110 cases].
    Zhang PP; Guo YT; Chu YQ; Ji QI; Lian Y; Li W; Yao LN
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):736-741. PubMed ID: 35894186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review.
    Chen Z; Zhang Y; Wang M; Islam MS; Liao P; Hu Y; Chen X
    Int J Biol Sci; 2022; 18(12):4629-4641. PubMed ID: 35874952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: a Prospective Clinical Trial (OMICRON).
    Kritikos A; Caruana G; Lazor-Blanchet C; Currat M; Chiche JD; Vollenweider P; Bart PA; Opota O; Greub G
    Microbiol Spectr; 2022 Dec; 10(6):e0392322. PubMed ID: 36346225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant.
    Tian D; Sun Y; Xu H; Ye Q
    J Med Virol; 2022 Jun; 94(6):2376-2383. PubMed ID: 35118687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Cases of Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections Caused by the Omicron Variant (B.1.1.529 Lineage) in International Travelers to Japan.
    Maruki T; Iwamoto N; Kanda K; Okumura N; Yamada G; Ishikane M; Ujiie M; Saito M; Fujimoto T; Kageyama T; Saito T; Saito S; Suzuki T; Ohmagari N
    Clin Infect Dis; 2022 Aug; 75(1):e354-e356. PubMed ID: 34979547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.